Tissue ischemia time affects gene and protein expression patterns within minutes following surgical tumor excision

BioTechniques

Volumn 36, Issue 6, 2004, Pages 1030-1037

  Spruessel, Annika ^a   Steimann, Garnet ^a   Jung, Mira ^b   Lee, Sung A ^b   Carr, Theresa ^b   Fentz, Anne Kristin ^a   Spangenberg, Joerg ^a   Zornig, Carsten ^a   Juhl, Hartmut H ^a   David, Kerstin A ^a  

^a ISRAELITISCHES KRANKENHAUS   (Germany)

^b GEORGETOWN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGENS; DESORPTION; GENES; LASERS; MASS SPECTROMETRY; PROTEINS; TISSUE; TUMORS;

CYTOSKELETAL GENES; DIAGNOSTIC MOLECULAR PATTERNS; PROTEIN EXPRESSION PATTERNS; SURFACE-ENHANCED LASER DESORPTION;

BIOTECHNOLOGY;

CARCINOEMBRYONIC ANTIGEN; HYPOXIA INDUCIBLE FACTOR 1ALPHA; PROTEIN C FOS; TUMOR ANTIGEN;

ARTICLE; CANCER SURGERY; COLON; COLON RESECTION; CONTROLLED STUDY; DEVICE; DNA MICROARRAY; GENE EXPRESSION; GENE EXPRESSION PROFILING; HUMAN; HUMAN CELL; HUMAN TISSUE; ISCHEMIA; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ISOLATION; SCREENING TEST; TIME OF FLIGHT MASS SPECTROMETRY;

EID: 2942617082     PISSN: 07366205     EISSN: None     Source Type: Journal    
DOI: 10.2144/04366rr04     Document Type: Article

References (37)

1. Hill, A.B., m.L. Nahrwold, D. Noonan, and P. Northrop. 1980. A comparison of methods of blood withdrawal and sample preparation for potassium measurements. Anesthesiology 53:60-63.
2. Yoshida, H. 2001. Analyses of preanalytical issue on samplings and samples. Rinsho Byori 49:211-218.
3. Gustafsson, T. and W.E. Kraus. 2001. Exercise-induced angiogenesis-related growth and transcription factors in skeletal muscle, and their modification in muscle pathology. Front. Biosci. 6:D75-D89.
4. Huang, J., R. Qi, J. Quackenbush, E. Dauway, E. Lazaridis, and T. Yeatman. 2001. Effects of ischemia on gene expression. J. Surg. Res. 99:222-227.
5. Iqbal, S. and H.J. Lenz. 2001. Determinants of prognosis and response to therapy in colorectal cancer. Curr. Oncol. Rep. 3:102-108.
6. Leach, R.M. and D.F. Treacher. 1998. Oxygen transport-2. Tissue hypoxia. BMJ 317:1370-1373.
7. Golub, T.R., D.K. Slonim, P. Tamayo, C. Huard, M. Gaasenbeek, J.P. Mesirov, II. Coller, M.L. Loh, et al. 1999. Molecular classification of cancer: class discovery and class prediction by gene expression monitoring. Science 286:531-537.
8. Khan, J., M.L. Bittner, Y. Chen, P.S. Meltzer, and J.M. Trent. 1999. DNA microarray technology: the anticipated impact on the study of human disease. Biochim. Biophys. Acta 1423:17-28.
9. Schubert, C.M. 2003. Microarray to be used as routine clinical screen. Nat. Med. 9:9.
10. Issaq, H.J., T.D. Veenstra, T.P. Conrads, and D. Felschow. 2002. The SELDI-TOF MS approach to proteomics: protein profiling and biomarker identification. Biochem. Biophys. Res. Commun. 292:587-592.
11. Paweletz, C.P., J.W. Gillespie, D.K. Ornstein, N.L. Simone, M.R. Brown, K.A. Cole, Q.-H. Wang, J. Huang, et al. 2000. Rapid protein display profiling of cancer progression directly from human tissue using a protein biochip. Drug Dev. Res. 49:34-42.
12. Srinivas, P.R., S. Srivastava, S. Hanash, and G.L. Wright, Jr. 2001. Proteomics in early detection of cancer. Clin. Chem. 47:1901-1911.
13. Heinicke, K., T. Hofer, R.H. Wenger, and M. Gassmann. 2002. The cellular response to hypoxia. Dtsch Zeitschr. Sportmed. 53:270-276.
14. Niess, A.M., E. Fehrenbach, H. Northoff, and H.-H. Dickhuth. 2002. Reactive species and oxidative stress in exercise and training adaption-an update. Dtsch Zeitschr. Sportmed. 53:345-353.
15. Chomczynski, P. and N. Sacchi. 1987. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162:156-159.
16. -ΔΔ Ct method. Methods 25:402-408.
17. Nowak Jr., T.S., J. Ikeda, and T. Nakajima. 1990. 70-kDa heat shock protein and c-fos gene expression after transient ischemia. Stroke 21:III107-III111.
18. Jorgensen, M.B., J. Deckert, D.C. Wright, and D.R. Gehlert. Delayed c-fos proto-oncogene expression in the rat hippocampus induced by transient global cerebral ischemia: an in situ hybridization study. Brain Res. 484:393-398.
19. Zhong, H., F. Agani, A.A. Baccala, E. Laughner, N. Rioseco-Camacho, W.B. Isaacs, J.W. Simons, and G.L. Semenza. 1998. Increased expression of hypoxia inducible factor-1alpha in rat and human prostate cancer. Cancer Res. 58:5280-5284.
20. Zhang, X., E.L. Bedard, R. Potter, R. Zhong, J. Alam, A.M. Choi, and P.J. Lee. 2002. Mitogen-activated protein kinases regulate HO-1 gene transcription after ischemia-reperfusion lung injury. Am. J. Physiol. Lung Cell Mol. Physiol. 283:L815-L829.
21. Wulfkuhle, J.D., K.C. McLean, C.P. Paweletz, D.C. Sgroi, B.J. Trock, P.S. Steeg, and E.F. Petricoin 3rd. 2001. New approaches to proteomic analysis of breast cancer. Proteomics 10:1205-1215.
22. Srinivas, P.R., M. Verma, Y. Zhao, and S. Srivastava. 2002. Proteomics for cancer biomarker discovery. Clin. Chem. 48:1160-1169.
23. Dash, A., I.P. Maine, S. Varambally, R. Shen, A.M. Chimbaiyan, and M.A. Rubin. 2002. Changes in differential gene expression because of warm ischemia time of radical prostatectomy specimens. Am. J. Pathol. 161:1743-1748.
24. Kelley, M.R., J.K. Jurgens, J. Tentler, N.V. Emanuele, S.E. Blutt, and M.A. Emanuele. 1993. Coupled reverse transcription-polymerase chain reaction (RT-PCR) technique is comparative, quantitative, and rapid: uses in alcohol research involving low abundance mRNA species such as hypothalamic LHRH and GRF. Alcohol 10: 185-189.
25. Gut, M., C.M. Leutenegger, J.B. Huder, N.C. Pedersen, and H. Lutz. 1999. One-tube fluorogenic reverse transcription-polymerase chain reaction for the quantitation of feline coronaviruses. J. Virol. Methods 77:37-46.
26. Jewell, U.R., I. Kvietikova, A. Scheid, C. Bauer, R.H. Wenger, and M. Gassmann. 2001. Induction of HIF-1α in response to hypoxia is instantaneous. FASEB J. 15:1312-1314.
27. Pugh, C.W. and P.J. Ratcliffe. 2003. Regulation of angiogenesis by hypoxia: role of the HIF system. Nat. Med. 9:677-684.
28. Wang, G.L. and G.L. Semenza. 1995. Purification and characterisation of hypoxia-inducible factor 1. Biol. Chem. 270:1230-1237.
29. 2 mediates CREB phosphorylation and c-fos expression during ischemia. Am. J. Physiol. Heart Circ. Physiol. 281:168-176.
30. Park, S.Y., H.S. Kim, E.K. Hong, and W.H. Kim. 2002. Expression of cytokeratins 7 and 20 in primary carcinomas of the stomach and colorectum and their value in the differential diagnosis of metastatic carcinomas to the ovary. Hum. Pathol. 33:1078-1085.
31. Shah, R.N., S. Badve, K. Papreddy, S. Schindler, W.B. Laskin, and A.V. Yeldandi. 2002. Expression of cytokeratin 20 in mucinous bronchioloalveolar carcinoma. Hum. Pathol. 33:915-920.
32. Jothy, S., S.Y. Yuan, and K. Shirota. 1993. Transcription of carcinoembryonic antigen in normal colon and colon carcinoma. In situ hybridization study and implication for a new in vivo functional model. Am. J. Pathol. 143:250-257.
33. Kuroki, M., F. Arakawa, H. Yamamoto, H. Shimura, Y. Ikehara, and Y. Matsuoka. 1988. Active Production and membrane anchoring of carcinoembryonic antigen observed in normal colon mucosa. Cancer Lett. 43:151-157.
34. Wirth, T., E. Soeth, F. Czubayko, and H. Juhl. 2002. Inhibition of endogenous carcinoembryonic antigen (CEA) increases the apoptotic rate of colon cancer cells and inhibits metastatic tumor growth. Clin. Exp. Metastasis 19:155-160.
35. Teixeira, C.R., S. Tanaka, K. Haruma, M. Yoshihara, K. Sumii, G. Kajiyama, and F. Shimamoto. 1994. Carcinoembryonic antigen staining patterns at the invasive tumor margin predict the malignant potential of colorectal carcinoma. Oncology 51:228-233.
36. Tokunaga, N., H. Kijima, T. Noto, Y. Osamura, S. Sadahiro, T. Tajima, and T. Mitomi. 1995. Immunhistochemical localization of carcinoembryonic antigen as a predictor of lymph node status in submucosa-invasive colorectal carcinoma. Dis. Colon Rectum 38:842-847.
37. Soeth, E., T. Wirth, H.J. List, S. Kumbhani, A. Petersen, M. Neumaier, F. Czubayko, and H. Juhl. 2001. Controlled ribozyme targeting demonstrates an antiapoptotic effect of carcinoembryonic antigen in HT29 colon cancer.cells. Clin. Cancer Res. 7:2022-2030.